 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Instruments & Supplies > V.I. Technologies, Inc.
 |
V.I. Technologies, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
VITEX divests plasma unit for $35 million,takes charge Aug 14 2001 04:40 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
V.I. Technologies (VITEX) bloody well cares about bad things being in your blood. The company uses its proprietary viral inactivation technologies to eliminate dangerous viruses from its blood products -- which include plasma, red blood cells, and platelets. Its INACTINE viral inactivation technology removes blood-borne viruses and bacteria. The company's transfusion plasma, created and sold with the American Red Cross under the name PLAS+SD, removes viruses such as hepatitis B and C and HIV. The company also supplies plasma fractions, which are purified into protein products, to Bayer Corporation. Ampersand Funds, of which directors Richard Charpie and Peter Parker are partners, owns about a third of VITEX.
COMPETITION |
 |
Baxter International Inc. (BAX)
Cerus Corporation (CERS)
Gambro AB (GAMBB)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 40.70
1-Yr. Sales Growth: 7.4%
Employees: 236
Revenue per employee: $172,457.63
KEY PEOPLE |
 |
John R. Barr
CEO
Thomas T. Higgins
CFO
CONTACT INFO |
 |
134 Coolidge Ave
Watertown, MA 02472
US
Phone: 617-926-1551
Fax: -
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |